Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10105421 Therapeutic composition with a botulinum neurotoxin

Patent 10105421 was granted and assigned to Merz Pharma on October, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Harold Victor Taylor0

Date of Patent

October 23, 2018

0

Patent Application Number

149505870

Date Filed

November 24, 2015

0

Patent Citations Received

US Patent 11911449 Albumin-free botulinum toxin formulations

0

US Patent 11285216 Animal protein-free pharmaceutical compositions

US Patent 11351232 Albumin-free botulinum toxin formulations

US Patent 11446382 Animal protein-free pharmaceutical compositions

US Patent 11471708 Injectable botulinum toxin formulations

US Patent 11524075 Animal protein-free pharmaceutical compositions

US Patent 11529398 Use of botulinum neurotoxin in the treatment of sialorrhea

US Patent 10709772 Use of botulinum neurotoxin in the treatment of sialorrhea

...

Patent Primary Examiner

Nita M. Minnifield

0

Patent abstract

The present invention pertains to pharmaceutical compositions which comprise botulinum toxin from Clostridium botulinum. The pharmaceutical compositions of the instant invention are not only free of a mammalian derived proteinaceous stabilizing agent but are free of any stabilizing protein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10105421 Therapeutic composition with a botulinum neurotoxin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool